Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioScience Health Innovations (BHIC) Revenue (2023 - 2025)

Historic Revenue for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to $1.1 million.

  • BioScience Health Innovations' Revenue rose 9746.6% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year increase of 20721.97%. This contributed to the annual value of $1.8 million for FY2024, which is 20873.18% up from last year.
  • BioScience Health Innovations' Revenue amounted to $1.1 million in Q3 2025, which was up 9746.6% from $1.8 million recorded in Q2 2025.
  • BioScience Health Innovations' Revenue's 5-year high stood at $1.8 million during Q2 2025, with a 5-year trough of $32337.0 in Q1 2023.
  • In the last 3 years, BioScience Health Innovations' Revenue had a median value of $384170.0 in 2024 and averaged $596229.2.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 75846.24% in 2024, then skyrocketed by 9746.6% in 2025.
  • Quarter analysis of 3 years shows BioScience Health Innovations' Revenue stood at $303628.0 in 2023, then skyrocketed by 100.98% to $610222.0 in 2024, then skyrocketed by 85.41% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.8 million for Q2 2025, and $1.2 million during Q1 2025.